Bibliographic Details
| Title: |
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis |
| Authors: |
Payne, Amanda B a, *, Watts, Janet A b, Mitchell, Patrick K b, Dascomb, Kristin c, Irving, Stephanie A d, Klein, Nicola P e, Grannis, Shaun J f, g, Ong, Toan C h, Ball, Sarah W b, DeSilva, Malini B i, Natarajan, Karthik j, Sheffield, Tamara c, Bride, Daniel c, Arndorfer, Julie c, Naleway, Allison L d, Koppolu, Padma d, Fireman, Bruce e, Zerbo, Ousseny e, Timbol, Julius e, Goddard, Kristin e, Dixon, Brian E g, k, Fadel, William F g, l, Rogerson, Colin g, m, Allen, Katie S g, k, Rao, Suchitra h, Mayer, David h, Barron, Michelle h, Reese, Sarah E b, Rowley, Elizabeth A K b, Najdowski, Morgan a, n, Ciesla, Allison Avrich a, n, Mak, Josephine a, Reeves, Emily L a, Akinsete, Omobosola O i, McEvoy, Charlene E i, Essien, Inih J i, Tenforde, Mark W a, Fleming-Dutra, Katherine E a, Link-Gelles, Ruth a, o |
| Source: |
In The Lancet 19-25 October 2024 404(10462):1547-1559 |
| Database: |
ScienceDirect |
